These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 12543661

  • 1. Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.
    Reipert A, Ehlert K, Kast T, Bierbaum G.
    Antimicrob Agents Chemother; 2003 Feb; 47(2):568-76. PubMed ID: 12543661
    [Abstract] [Full Text] [Related]

  • 2. Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility.
    Jansen A, Szekat C, Schröder W, Wolz C, Goerke C, Lee JC, Türck M, Bierbaum G.
    BMC Microbiol; 2013 Mar 22; 13():65. PubMed ID: 23522028
    [Abstract] [Full Text] [Related]

  • 3. Role of the msaABCR Operon in Cell Wall Biosynthesis, Autolysis, Integrity, and Antibiotic Resistance in Staphylococcus aureus.
    G C B, Sahukhal GS, Elasri MO.
    Antimicrob Agents Chemother; 2019 Oct 22; 63(10):. PubMed ID: 31307991
    [Abstract] [Full Text] [Related]

  • 4. Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus.
    Jansen A, Türck M, Szekat C, Nagel M, Clever I, Bierbaum G.
    Int J Med Microbiol; 2007 Jul 22; 297(4):205-15. PubMed ID: 17418637
    [Abstract] [Full Text] [Related]

  • 5. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.
    Hort M, Bertsche U, Nozinovic S, Dietrich A, Schrötter AS, Mildenberger L, Axtmann K, Berscheid A, Bierbaum G.
    Microbiol Spectr; 2021 Oct 31; 9(2):e0052821. PubMed ID: 34668723
    [Abstract] [Full Text] [Related]

  • 6. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.
    Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy MC, El-Solh N, Ferraz V, Hiramatsu K.
    J Clin Microbiol; 2003 Jan 31; 41(1):5-14. PubMed ID: 12517819
    [Abstract] [Full Text] [Related]

  • 7. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
    Katayama Y, Sekine M, Hishinuma T, Aiba Y, Hiramatsu K.
    Antimicrob Agents Chemother; 2016 Jun 31; 60(6):3730-42. PubMed ID: 27067329
    [Abstract] [Full Text] [Related]

  • 8. "Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.
    Saito M, Katayama Y, Hishinuma T, Iwamoto A, Aiba Y, Kuwahara-Arai K, Cui L, Matsuo M, Aritaka N, Hiramatsu K.
    Antimicrob Agents Chemother; 2014 Sep 31; 58(9):5024-35. PubMed ID: 24841271
    [Abstract] [Full Text] [Related]

  • 9. Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan.
    Hanaki H, Hososaka Y, Yanagisawa C, Otsuka Y, Nagasawa Z, Nakae T, Sunakawa K.
    J Infect Chemother; 2007 Apr 31; 13(2):118-21. PubMed ID: 17458681
    [Abstract] [Full Text] [Related]

  • 10. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Howden BP, Johnson PD, Ward PB, Stinear TP, Davies JK.
    Antimicrob Agents Chemother; 2006 Sep 31; 50(9):3039-47. PubMed ID: 16940100
    [Abstract] [Full Text] [Related]

  • 11. Different Vancomycin-Intermediate Staphylococcus aureus Phenotypes Selected from the Same ST100-hVISA Parental Strain.
    Di Gregorio S, Fernandez S, Cuirolo A, Verlaine O, Amoroso A, Mengin-Lecreulx D, Famiglietti A, Joris B, Mollerach M.
    Microb Drug Resist; 2017 Jan 31; 23(1):44-50. PubMed ID: 27991847
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus.
    Ozmen Capin BB, Tekeli A, Karahan ZC.
    Microb Drug Resist; 2020 Mar 31; 26(3):238-244. PubMed ID: 31545160
    [Abstract] [Full Text] [Related]

  • 13. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.
    Kim MN, Hwang SH, Pyo YJ, Mun HM, Pai CH.
    J Clin Microbiol; 2002 Apr 31; 40(4):1376-80. PubMed ID: 11923359
    [Abstract] [Full Text] [Related]

  • 14. Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds.
    Pfeltz RF, Singh VK, Schmidt JL, Batten MA, Baranyk CS, Nadakavukaren MJ, Jayaswal RK, Wilkinson BJ.
    Antimicrob Agents Chemother; 2000 Feb 31; 44(2):294-303. PubMed ID: 10639353
    [Abstract] [Full Text] [Related]

  • 15. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.
    Shoji M, Cui L, Iizuka R, Komoto A, Neoh HM, Watanabe Y, Hishinuma T, Hiramatsu K.
    Antimicrob Agents Chemother; 2011 Aug 31; 55(8):3870-81. PubMed ID: 21628539
    [Abstract] [Full Text] [Related]

  • 16. Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital.
    Hsueh PR, Lee SY, Perng CL, Chang TY, Lu JJ.
    Int J Antimicrob Agents; 2010 Oct 31; 36(4):307-12. PubMed ID: 20685086
    [Abstract] [Full Text] [Related]

  • 17. Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate.
    Boyle-Vavra S, Carey RB, Daum RS.
    J Antimicrob Chemother; 2001 Nov 31; 48(5):617-25. PubMed ID: 11679550
    [Abstract] [Full Text] [Related]

  • 18. Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureus.
    Adhikari RP, Scales GC, Kobayashi K, Smith JM, Berger-Bächi B, Cook GM.
    J Antimicrob Chemother; 2004 Aug 31; 54(2):360-3. PubMed ID: 15243027
    [Abstract] [Full Text] [Related]

  • 19. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
    Ghahremani M, Jazani NH, Sharifi Y.
    J Glob Antimicrob Resist; 2018 Sep 31; 14():4-9. PubMed ID: 29454049
    [Abstract] [Full Text] [Related]

  • 20. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.
    Cui L, Tominaga E, Neoh HM, Hiramatsu K.
    Antimicrob Agents Chemother; 2006 Mar 31; 50(3):1079-82. PubMed ID: 16495273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.